Related Experiment Video
Updated: Dec 27, 2025

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
Published on: March 23, 2022
Difficult diagnosis of cardiac haemochromatosis: a case report
Vaida Sudmantaitė1, Jelena Čelutkienė1, Sigita Glaveckaite1
1Clinic of Cardiac and Vascular Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Santariškių 2, LT-08661 Vilnius, Lithuania.
Insights
Early detection of iron overload cardiomyopathy is crucial for preventing heart failure. This case highlights how recognizing associated syndromes can lead to earlier diagnosis and treatment of hereditary hemochromatosis, improving cardiac function.
Area of Science:
- Cardiology
- Genetics
- Hepatology
Background:
- Primary iron overload cardiomyopathy is a significant cause of heart failure, often progressing silently.
- Timely diagnosis requires awareness and clinical vigilance for this systemic disorder.
Observation:
- A 48-year-old man presented with atrial fibrillation and multiple systemic syndromes including cardiomyopathy, cirrhosis, and diabetes mellitus.
- Elevated iron metabolism markers, cardiac imaging showing biventricular dysfunction, and myocardial/hepatic siderosis confirmed iron overload.
- Hereditary Type I hemochromatosis was diagnosed via genetic testing.
Findings:
- Treatment with deferiprone chelation and phlebotomies improved cardiac function and reduced iron accumulation.
- Complicating syndromes were identified before the underlying hemochromatosis in this patient.
- Cardiac hemochromatosis should be suspected in unexplained heart failure, especially with family history or other organ involvement.
Implications:
- Screening for iron overload using transferrin saturation and serum ferritin is recommended for at-risk patients.
- Non-invasive imaging tests are vital for confirming organ involvement in suspected systemic iron overload.
- Prompt diagnosis and treatment of hemochromatosis can prevent or reverse cardiac dysfunction.
Background:
Primary iron overload cardiomyopathy is an important and potentially preventable cause of heart failure (HF), usually manifesting in the 4-5th decade of life. Patients may be asymptomatic early in the disease with hidden progression of cardiac dysfunction. The challenge of timely detection is an awareness of this systemic disorder and an adequate degree of clinical vigilance.
Case Summary:
A 48-year-old man was referred to the university clinic due to the episode of atrial fibrillation. The specific features of bronze skin and yellow eyes together with a combination of syndromes (cardiomyopathy, cirrhosis, ascites and portal hypertension, diabetes mellitus, and chronic kidney disease) stimulated the testing of iron metabolism markers, which were far above the normal range. Echocardiography and cardiac magnetic resonance (CMR) showed the dilatation of all cardiac cavities and biventricular systolic dysfunction. CMR T2* mapping was consistent with the diagnosis of myocardial and hepatic siderosis. Hereditary Type I haemochromatosis was confirmed by a genetic test. After 6 months of standard HF treatment, chelation therapy with deferiprone and regular phlebotomies imaging tests showed a reduction of ventricular and atrial volumes, an improvement in the cardiac systolic function and a decrease of iron accumulation.
Discussion:
In this case, complicating syndromes were detected earlier than underlying disease of primary haemochromatosis. Cardiac haemochromatosis should be considered in any patient with unexplained HF, especially in the case of a positive family history, abnormal liver enzymes, endocrinopathies, or evidence of involvement of other organ systems. Screening for systemic iron overload with transferrin saturation and serum ferritin is the first step. Further non-invasive imaging tests should be done to confirm organ involvement.
More Related Videos
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
09:16Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
Published on: February 28, 2018
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Mitral Stenosis II: Clinical features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies